Telo Genomics Corp. (TDSGF)
OTCMKTS
· Delayed Price · Currency is USD
0.0550
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT
Telo Genomics Cash Flow Statement
Financials in millions CAD. Fiscal year is July - June.
Millions CAD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Net Income | -2.37 | -2.71 | -2.82 | -2.11 | -1.07 | -1.24 | Upgrade
|
| Depreciation & Amortization | 0.03 | 0.04 | 0.03 | 0.06 | 0.06 | 0.06 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | -0.04 | 0.06 | 0.16 | 0.15 | 0.14 | 0.36 | Upgrade
|
| Other Operating Activities | -0.01 | -0.01 | - | - | -0.19 | -0.1 | Upgrade
|
| Change in Accounts Receivable | 0.04 | 0.03 | -0.03 | 0.06 | -0.05 | -0.01 | Upgrade
|
| Change in Accounts Payable | 0.33 | 0.11 | 0.07 | 0.08 | -0.04 | -0.15 | Upgrade
|
| Change in Other Net Operating Assets | 0.06 | 0.01 | -0.05 | -0.03 | 0.04 | -0.04 | Upgrade
|
| Operating Cash Flow | -1.96 | -2.46 | -2.63 | -1.79 | -1.1 | -1.12 | Upgrade
|
| Capital Expenditures | -0 | -0.01 | -0.07 | -0.03 | -0.01 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | - | -0.01 | Upgrade
|
| Investing Cash Flow | -0 | -0.01 | -0.07 | -0.03 | -0.01 | -0.01 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 0.35 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 0.04 | Upgrade
|
| Total Debt Issued | - | - | - | - | - | 0.39 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -0.02 | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.02 | -0.01 | - | - | - | Upgrade
|
| Total Debt Repaid | -0.02 | -0.02 | -0.01 | - | -0.02 | - | Upgrade
|
| Net Debt Issued (Repaid) | -0.02 | -0.02 | -0.01 | - | -0.02 | 0.39 | Upgrade
|
| Issuance of Common Stock | 3.2 | 0.65 | 2.89 | 0.89 | 3.99 | 1.75 | Upgrade
|
| Other Financing Activities | -0.26 | -0.04 | -0.21 | -0.02 | -0.15 | -0.11 | Upgrade
|
| Financing Cash Flow | 2.92 | 0.59 | 2.68 | 0.88 | 3.83 | 2.03 | Upgrade
|
| Net Cash Flow | 0.95 | -1.88 | -0.02 | -0.94 | 2.72 | 0.9 | Upgrade
|
| Free Cash Flow | -1.96 | -2.46 | -2.7 | -1.82 | -1.11 | -1.12 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.04 | -0.04 | -0.03 | -0.02 | -0.04 | Upgrade
|
| Levered Free Cash Flow | -1.1 | -1.46 | -1.62 | -1.03 | -0.84 | -1.15 | Upgrade
|
| Unlevered Free Cash Flow | -1.1 | -1.46 | -1.62 | -1.03 | -0.84 | -1.13 | Upgrade
|
| Change in Net Working Capital | -0.42 | -0.14 | -0.01 | -0.11 | 0.25 | 0.73 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.